Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Potential new target for cancer treatment

08.05.2007
A discovery made by a research team at the Sahlgrenska Academy in Göteborg may lead to new treatments for lung cancer and blood cancer, among others. By stopping the production of a particular enzyme in mice, they reduced the development of tumors, and the mice survived considerably longer.

In many forms of cancer the growth of tumors and their capacity to spread is stimulated by a number of CAAX proteins. This has led to intensive research into how to block the activity of these proteins.

"The enzyme we are studying develops CAAX proteins so that they will take on the properties that stimulate cancer growth. By blocking this enzyme, we may be able to reduce the modification of CAAX proteins in a new cancer model in mice," says Associate Professor Martin Bergö, who directs this research at the Wallenberg Laboratory, Sahlgrenska Academy.

The research team uses a genetically modified mouse that produces a muted and constantly active CAAX protein. This is a new model for an extremely aggressive lung cancer and a mild form of blood cancer. In these mice, the production of an enzyme called GGTas1 can also be stopped.

"When we inhibited the production of the enzyme, tumor development decreased dramatically. The mice survived considerably longer, and all signs of blood cancer disappeared. A drug that blocks this enzyme can be an effective future cancer treatment," says Martin Bergö.

The findings strongly indicate that the enzyme GGTas1 is a promising target for cancer treatment. At the cell level, inhibition of the enzyme resulted in blocked cell growth and decreased cell mobility.

"Another interesting discovery in this study was that many types of cells appear to be able to survive without the enzyme. This is important from the point of view of toxicology, since you want a drug to attack only the cancer cells and not normal cells and tissues," says Martin Bergö.

The research team is now pursuing the question of whether GGTas1 can also be an effective target for treating other types of cancer. They will also be ensuring that inhibiting this enzyme does not damage other cell types and tissues.

For more information, please contact: Associate Professor Martin Bergö, phone: +46(0)31-342 78 58; e-mail: martin.bergo@wlab.gu.se Journal: Journal of Clinical Investigation Title of article: GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer Authors: Anna-Karin M. Sjögren, Karin M.E. Andersson, Meng Liu, Briony A. Cutts, Christin Karlsson, Annika M. Wahlström, Martin Dalin, Carolyn Weinbaum, Patrick J. Casey, Andrej Tarkowski, Birgitta Swolin, Stephen G. Young, Martin O. Bergö

Elin Lindström Claessen | idw
Further information:
http://www.vr.se

More articles from Health and Medicine:

nachricht Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

From rocks in Colorado, evidence of a 'chaotic solar system'

23.02.2017 | Physics and Astronomy

'Quartz' crystals at the Earth's core power its magnetic field

23.02.2017 | Earth Sciences

Antimicrobial substances identified in Komodo dragon blood

23.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>